Annie Yoshiyama

Annie Yoshiyama is a seasoned finance executive currently serving as Senior Vice President of Finance and Corporate Controller at Allogene Therapeutics since April 2024. Prior to this role, Annie held the position of VP Finance and Corporate Controller at AN2 Therapeutics, where responsibilities included leading quarterly Audit Committee meetings and managing financial reporting. Annie's extensive experience at Tricida, Inc. included roles as Senior Vice President of Finance and Chief Accounting Officer, where notable achievements included overseeing a $42M equity financing and building a high-performing finance team. Previous positions at Dolby Laboratories and PwC further enriched Annie's expertise in financial reporting, technical accounting, and auditing. Annie holds both a Master's and Bachelor's degree in Accounting from the University of Southern California.